Patheon explains the importance of mergers and acquisitions as the company strengthens its position in the sector.
Under the leadership of CEO James Mullen, Patheon has transformed into a leading global provider of high-quality drug development and delivery solutions to the pharmaceuticals and biopharma sectors. This transformation was based on a four-pronged business strategy: strengthen the core operations, sell the business differently, enter logical adjacencies and drive industry consolidation.